|
Volumn 39, Issue 9, 2007, Pages 1057-1059
|
Cancer drugs to treat birth defects
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE;
ANTINEOPLASTIC AGENT;
FIBROBLAST GROWTH FACTOR RECEPTOR 2;
MITOGEN ACTIVATED PROTEIN KINASE KINASE 1;
MITOGEN ACTIVATED PROTEIN KINASE KINASE 2;
ACROCEPHALOSYNDACTYLY;
BIRTH DEFECT;
CONGENITAL MALFORMATION;
CRANIOFACIAL MALFORMATION;
DRUG INHIBITION;
GENE MUTATION;
GENETIC CODE;
NONHUMAN;
PHENOTYPE;
PRIORITY JOURNAL;
SHORT SURVEY;
SOMATIC MUTATION;
ACROCEPHALOSYNDACTYLIA;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CONGENITAL ABNORMALITIES;
DISEASE MODELS, ANIMAL;
HUMANS;
MICE;
MITOGEN-ACTIVATED PROTEIN KINASES;
MODELS, BIOLOGICAL;
RAS PROTEINS;
SIGNAL TRANSDUCTION;
|
EID: 34548332487
PISSN: 10614036
EISSN: 15461718
Source Type: Journal
DOI: 10.1038/ng0907-1057 Document Type: Short Survey |
Times cited : (29)
|
References (15)
|